Literature DB >> 28459341

AJRCCM: 100-Year Anniversary. Focus on Tuberculosis.

Neil W Schluger1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28459341     DOI: 10.1164/rccm.201703-0446ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.

Authors:  Katharine A Fox; Daniela E Kirwan; Ashley M Whittington; Nitya Krishnan; Brian D Robertson; Robert H Gilman; José W López; Shivani Singh; Joanna C Porter; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

2.  Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.

Authors:  Chiara Della Bella; Michele Spinicci; Alessia Grassi; Filippo Bartalesi; Marisa Benagiano; Katja Truthmann; Simona Tapinassi; Arianna Troilo; Sofia D'Elios; Heba Alnwaisri; Eduard Shuralev; Mahavir Singh; Alessandro Bartoloni; Mario Milco D'Elios
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

3.  Mycobacterial identification on homogenised biopsy facilitates the early diagnosis and treatment of laryngeal tuberculosis.

Authors:  Zhenjun Yu; Ruyue Lu; Meifu Gan; Xi Tu; Zebao He
Journal:  Open Med (Wars)       Date:  2020-06-05

4.  Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers.

Authors:  A Albors-Vaquer; A Rizvi; M Matzapetakis; P Lamosa; A V Coelho; A B Patel; S C Mande; S Gaddam; A Pineda-Lucena; S Banerjee; L Puchades-Carrasco
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

5.  Combining bioinformatics and biological detection to identify novel biomarkers for diagnosis and prognosis of pulmonary tuberculosis.

Authors:  Guanren Zhao; Xiaobo Luo; Xue Han; Zhen Liu
Journal:  Saudi Med J       Date:  2020-04       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.